Measurement of the effectiveness of tedizolid against methicillin resistant staphylococcus aureus in vitro

dc.contributor.advisorSzabó, Judit
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Orvosi Mikrobiológiai Intézethu_HU
dc.contributor.authorTasie, Onyinyechukwu Eme
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDombrádi, Zsuzsanna
dc.contributor.opponentFehér, Pálma
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Orvosi Mikrobiológiai Intézethu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Gyógyszerésztudományi Kar::Gyógyszertechnológiai Tanszékhu_HU
dc.date.accessioned2020-02-04T11:56:46Z
dc.date.available2020-02-04T11:56:46Z
dc.date.created2019-08-23
dc.description.abstractAntimicrobial resistance in pathogens possess a serious public health concern today. A global effort to keep pace with this growing problem has led to the development of new and more effective anti-infective agents. One such example, tedizolid, is a second-generation (extended-spectrum) oxazolidinone with remarkable potency against a wide range of Gram-positive pathogens. It affects bacteriostatic action by binding to 23S ribosomal RNA (rRNA) in the 50S subunit of the ribosome, thus inhibiting protein synthesis. Tedizolid exhibits higher potency than other oxazolidinones including linezolid. It has been approved for the treatment of infections by highly resistant strains like methicillin-resistant Staphylococcus aureus (MRSA).hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.coursespecImmunológia, sejt- és mikrobiológiahu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent38hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/280312
dc.language.isoenhu_HU
dc.subjectMethicillin-Resistant Staphylococcus aureushu_HU
dc.subjectTedizolidhu_HU
dc.subjectIn-vitrohu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleMeasurement of the effectiveness of tedizolid against methicillin resistant staphylococcus aureus in vitrohu_HU
Fájlok